Abstract

Limited data is available on long-term outcome predictions for patients with acute-on-chronic liver failure (ACLF) in an intensive care unit (ICU) setting. Assessing the reliability and accuracy of several mortality prediction models for these patients is helpful. Two hundred forty-nine consecutive patients with ACLF and admittance to the liver ICU in a single center in northern Taiwan between December 2012 and March 2015 were enrolled in the study and were tracked until February 2017. Ninety-one patients had chronic hepatitis B-related cirrhosis. Clinical features and laboratory data were collected at or within 24 h of the first ICU admission course. Eight commonly used clinical scores in chronic liver disease were calculated. The primary endpoint was overall survival. Acute physiology and chronic health evaluation (APACHE) III and chronic liver failure consortium (CLIF-C) ACLF scores were significantly superior to other models in predicting overall mortality as determined by time-dependent receiver operating characteristic (ROC) curve analysis (area under the ROC curve (AUROC): 0.817). Subgroup analysis of patients with chronic hepatitis B-related cirrhosis displayed similar results. CLIF-C organ function (OF), CLIF-C ACLF, and APACHE III scores were statistically superior to the mortality probability model III at zero hours (MPM0-III) and the simplified acute physiology (SAP) III scores in predicting 28-day mortality. In conclusion, for 28-day and overall mortality prediction of patients with ACLF admitted to the ICU, APACHE III, CLIF-OF, and CLIF-C ACLF scores might outperform other models. Further prospective study is warranted.

Highlights

  • Acute-on-chronic liver failure (ACLF) is a recently recognized syndrome characterized by acute cirrhotic decompensation, organ failure, and marked short-term mortality (28-day mortality of 30%~40%) [1] as defined in the CANONIC study [2]

  • The results showed that Acute physiology and chronic health evaluation (APACHE) III and chronic liver failure consortium (CLIF-C) ACLF scores were significantly superior to other models in predicting overall mortality as determined by time-dependent receiver operating characteristic (ROC) curve analysis (AUROC: 0.817)

  • In predicting the 28-day mortality, APACHE III showed no significant difference to CLIF-C organ function (OF) CLIF-C ACLF, and model for end-stage liver disease (MELD)

Read more

Summary

Introduction

Acute-on-chronic liver failure (ACLF) is a recently recognized syndrome characterized by acute cirrhotic decompensation, organ failure, and marked short-term mortality (28-day mortality of 30%~40%) [1] as defined in the CANONIC study [2]. This syndrome usually requires admission to an intensive care unit [3], yet in contrast to cirrhotic decompensation, which is considered irreversible given the loss of regenerative potential, ACLF is reversible if the precipitating event can be managed [4]. There is, a need to identify the most reliable prognostic model as well as to establish cutoff values for these critically ill patients

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call